Photopheresis or extracorporeal photochemotherapy (ECP) is an immunomodulating
procedure that has been available for the treatment of cutaneous T‐cell lymphoma (CTCL) …

Primary cutaneous T-cell lymphomas are a heterogenous group of non-Hodgkin
lymphomas. The characteristic clinicopathologic and immunophenotypic features and …

Product liability: The publisher can give no guarantee for all the information contained in this
book. This does also refer to information about drug dosage and application thereof. In every …

Extracorporeal photochemotherapy was originally conceived for the treatment of cutaneous
T-cell lymphoma (CTCL) and as well as other T-cell mediated diseases. Evidence collected …

Background: Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are potentially severe
diseases. In drug-resistant PV and pemphigus foliaceus, long-term adjuvant treatment with …

Background: The management of systemic sclerosis remains unsatisfactory. Thus far, the
action of extracorporeal photopheresis (ECP) in severe systemic scleroderma has been …

Abstract Systemic sclerosis (scleroderma)(SSc) is a rare autoimmune disorder characterized
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …

Mycosis fungoides (MF) and Sézary syndrome (SS) are two well-characterized skin limited
and leukemic subtypes of cutaneous T-cell lymphoma (CTCL), respectively. Progressive …

Background: Extracorporeal photopheresis (ECP) is recommended for the treatment of
Sézary syndrome (SS), the leukemic variant of cutaneous T‐cell lymphoma (CTCL). Several …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy based upon pheresis of light‐sensitive cells. Whole blood is removed from patients …